Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Tender notice |
| Buyer: | St George's University Hospitals NHS Foundation Trust |
| Main Category: | Services |
| Procurement Method: | Open procedure |
| Submission Methods: | Electronic submission, Written |
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
20 January 2025
Closed
Estimated Value
£2,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →| Tender Status: |
| Closed |
| Estimated Value (ex. VAT): | £2,000,000 |
| Release Date: | 17 December 2024 |
| Application Deadline: | 20 January 2025 |
| Procurement ID (OCID): | ocds-h6vhtk-04c89c |
| Notice Reference: | 040548-2024 |
All 2 notices for this procurement, oldest first.
Provision of Non-Invasive Pre-Natal Testing Service
Provision of Non-Invasive Pre-natal Testing
Earlier notices predate the Procurement Act 2023 (commenced 24 Feb 2025) and therefore don't carry UK1–UK17 codes.
The St George’s Antenatal Fetal Evaluation (SAFE) test is a Non Invasive Prenatal Testing (NIPT) service based at St George’s University Hospitals NHS Foundation Trust, screening for Down’s, Edwards’ and Patau’s syndromes, in line with UK National Screening Committee (UKNSC) recommendations and NHS England requirements. In some instances, fetal sexing is performed in addition to the main trisomy’s. The SAFE test has been set up as a collaboration between the Fetal Medicine Unit and the St George’s Genomics Service, which is a UKAS accredited medical laboratory. The service provides NIPT to approximately one third of the NHS maternity services in England and several private clinical services performing 4,000-5,000 tests annually.<br/><br/>This invitation to tender gives the requirement to supply a complete laboratory test setup including reagent test kits for NIPT, all equipment, associated software and LIMS and equipment servicing. The test should be commercially available and CE marked for In Vitro diagnostic use ideally compliant to ISO13485. It should detect aneuploidy of chromosomes 13, 18 and 21 and be able to determine fetal sex within the specified sensitivity and specificity thresholds as a minimum requirement.<br/><br/>The supplier must provide reagents, software and protocols sufficient to produce an end result on suitable equipment designated by the supplier. Resulting data must be clearly reportable and be usable by The SAFE Test personnel in a flexible and secure manner.<br/><br/>The service must be provided to diagnostic standards, incorporating a complete CE/IVDD compliant workflow, to ensure data can be used for clinical interpretation. Samples must be analysed within the given timeframe, data must meet the minimum specified requirements and results issued in a customisable and easily interpretable format.<br/><br/>The majority of samples processed are commissioned by NHSE with a contract running until March 2026. In the event St George’s is not re-procured by NHSE to provide this service beyond this point, it is likely that the service may have to terminate its contract with the supplier.
Document pack· 1 file
Published contracts in the last 12 months
34
total contracts
£13.3m
total value
£700,826
average contract size
Typical categories
STG - Hepatitis C Vehicle Mobile Unit
St George's University Hospitals NHS Foundation Trust · WAC-606599
Lymphoedema Garments and Accessories
St George's University Hospitals NHS Foundation Trust · WAC-602593
St Georges Hospital Community Estates Hard and Soft FM Tender
St George's University Hospitals NHS Foundation Trust · WAC-576933